supplemental_figure_2_ – Supplemental material for Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment

Le Large, Tessa Ya Sung; El Hassouni, Btissame; Funel, Niccola; Kok, Bart; Piersma, Sander R.; Pham, Thang V.; Olive, Kenneth P.; Kazemier, Geert; van Laarhoven, Hanneke W.M.; Jimenez, Connie R.; F. Bijlsma, Maarten; Giovannetti, Elisa

doi:10.25384/SAGE.8184707.v1

supplemental_figure_2_.pdf (277.98 kB)

supplemental_figure_2_ – Supplemental material for Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment

journal contribution

posted on 2019-05-10, 12:00 authored by Tessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, Bart Kok, Sander R. Piersma, Thang V. Pham, Kenneth P. Olive, Geert Kazemier, Hanneke W.M. van Laarhoven, Connie R. Jimenez, Maarten F. Bijlsma, Elisa Giovannetti

Supplemental material, supplemental_figure_2_ for Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment by Tessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, Bart Kok, Sander R. Piersma, Thang V. Pham, Kenneth P. Olive, Geert Kazemier, Hanneke W.M. van Laarhoven, Connie R. Jimenez, Maarten F. Bijlsma and Elisa Giovannetti in Therapeutic Advances in Medical Oncology